Company Filing History:
Years Active: 2022
Title: Matjaz Brvar: Innovator in GPR120 Modulation
Introduction
Matjaz Brvar is a notable inventor based in Zagorje ob Savi, Slovenia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate G-protein-coupled receptors. His work is particularly relevant in the context of metabolic diseases, including diabetes and obesity.
Latest Patents
Matjaz Brvar holds a patent for "Tetrahydro-benzo[d]azepine derivatives as GPR120 modulators." This patent describes novel tetrahydroisoquinoline and tetrahydrobenzazepine compounds capable of modulating the GPR120 receptor. These compounds are designed for use in controlling insulin levels in vivo and for treating conditions such as diabetes, inflammation, obesity, and other metabolic diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Matjaz has worked with various organizations, including Caldan Therapeutics Limited and the Chemical Institute. His experience in these companies has allowed him to develop innovative solutions in the pharmaceutical industry.
Collaborations
Matjaz has collaborated with notable professionals in his field, including Jane Theresa Brown and Stephen Connolly. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Matjaz Brvar is a distinguished inventor whose work in GPR120 modulation has the potential to impact the treatment of metabolic diseases significantly. His innovative approach and collaborations highlight his commitment to advancing pharmaceutical science.